1. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291-310.
https://doi.org/10.1016/j.preghy.2018.08.022 [
DOI:10.1016/j.preghy.2018.05.004] [
PMID]
2. Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018;19(5):1-29. [
DOI:10.3390/ijms19051496] [
PMID] [
PMCID]
3. Weissgerber TL, Mudd LM. Preeclampsia and Diabetes. Curr Diab Rep. 2015;15(9):1-10. [
DOI:10.1007/s11892-015-0579-4] [
PMID] [
PMCID]
4. Su X, Liu Y, Li G, Liu X, Huang S, Duan T, et al. Associations of Hypothyroxinemia With Risk of Preeclampsia-Eclampsia and Gestational Hypertension. Front Endocrinol (Lausanne). 2021;12( 777152):1-9. [
DOI:10.3389/fendo.2021.777152] [
PMID] [
PMCID]
5. Singh CK, Chhabra G, Ndiaye MA, Garcia-Peterson LM, MacK NJ, Ahmad N. The Role of Sirtuins in Antioxidant and Redox Signaling. Antioxidants Redox Signal.2018;28(8):643-61. [
DOI:10.1089/ars.2017.7290] [
PMID] [
PMCID]
6. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World allergy Organ J. 2012;5(1):9-19. [
DOI:10.1097/WOX.0b013e3182439613] [
PMID] [
PMCID]
7. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2018;54(4):287-93. [
DOI:10.1016/j.ajme.2017.09.001]
8. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769-89. [
DOI:10.1080/03602530600971974] [
PMID]
9. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47(9):1304-9. [
DOI:10.1016/j.freeradbiomed.2009.07.035] [
PMID] [
PMCID]
10. Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2 - An update. Free Radic Biol Med. 2014;66:36-44. [
DOI:10.1016/j.freeradbiomed.2013.02.008] [
PMID] [
PMCID]
11. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122(4):369-82. [
DOI:10.1007/s00418-004-0677-x] [
PMID]
12. Basu J, Bendek B, Agamasu E, Salafia CM, Mishra A, Benfield N, et al. Placental Oxidative Status throughout Normal Gestation in Women with Uncomplicated Pregnancies. Obstet Gynecol Int. 2015;2015(276095):1-6. [
DOI:10.1155/2015/276095] [
PMID] [
PMCID]
13. Incalza MA, D'Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1-19. [
DOI:10.1016/j.vph.2017.05.005] [
PMID]
14. Guller S. Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb Res. 2009;124(4):389-92. [
DOI:10.1016/j.thromres.2009.05.016] [
PMID] [
PMCID]
15. Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol. 2005;25(1):56-60. [
DOI:10.1016/j.semnephrol.2004.09.009] [
PMID]
16. Bainbridge SA, Roberts JM. Uric Acid as a Pathogenic Factor in Preeclampsia. Placenta. 2008;29(SUPPL A):S67-72. [
DOI:10.1016/j.placenta.2007.11.001] [
PMID] [
PMCID]
17. Manjareeka M, Nanda S. Elevated levels of serum uric acid, creatinine or urea in preeclamptic women. Int J Med Sci Public Heal. 2013;2:43-7. [
DOI:10.5455/ijmsph.2013.2.43-47]
18. Dacaj R, Izetbegovic S, Stojkanovic G, Dreshaj S. Elevated Liver Enzymes in Cases of Preeclampsia and Intrauterine Growth Restriction. Med Arch (Sarajevo, Bosnia Herzegovina). 2016;70:44-7. [
DOI:10.5455/medarh.2016.70.44-47] [
PMID] [
PMCID]
19. Hartikainen JM, Tengström M, Winqvist R, Jukkola-Vuorinen A, Pylkäs K, Kosma VM, et al. KEAP1 genetic polymorphisms associate with breast cancer risk and survival outcomes. Clin Cancer Res. 2015;21(7):1591-601. [
DOI:10.1158/1078-0432.CCR-14-1887] [
PMID]
20. Testa A, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, et al. A polymorphism in a major antiox idant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: An explorator y study. J Hypertens. 2016;34(5):928-34. [
DOI:10.1097/HJH.0000000000000878] [
PMID]